Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Paul George Mathew, M.D.

Concepts (185)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Migraine Disorders11202217121.870 Why?
Receptors, Platelet-Derived Growth Factor420111781.160 Why?
Headache6202012611.080 Why?
Headache Disorders, Secondary22016340.870 Why?
Taxoids1020116650.810 Why?
Headache Disorders, Primary22014390.800 Why?
Preoperative Care3201522520.730 Why?
Headache Disorders320241520.720 Why?
Cranial Nerve Diseases120211110.710 Why?
Tryptamines32019930.700 Why?
Post-Traumatic Headache12021690.690 Why?
Neuralgia220246190.610 Why?
Nausea120206820.580 Why?
Paternalism12016490.530 Why?
Advance Care Planning120236980.500 Why?
Prostatic Neoplasms152011110970.490 Why?
Piperazines5201125480.490 Why?
Auditory Threshold120163690.460 Why?
Advance Directives120162490.450 Why?
Intracranial Hypotension12014420.450 Why?
Bone Neoplasms7201125630.440 Why?
Tension-Type Headache22011760.440 Why?
Personal Autonomy120163160.430 Why?
Neuromuscular Agents120141480.410 Why?
Certification120164200.400 Why?
Analgesics3201410710.400 Why?
Premenstrual Syndrome120131110.390 Why?
Vasoconstriction120145910.370 Why?
Botulinum Toxins, Type A120142380.360 Why?
Education, Medical, Continuing120168290.360 Why?
Pyrimidines5201130440.320 Why?
Menstrual Cycle120135460.320 Why?
Smoking Cessation1202020850.310 Why?
Neurology120167850.290 Why?
Leuprolide120083130.270 Why?
Data Collection1201633210.270 Why?
Patient Preference120149470.260 Why?
Estrogens1201315360.260 Why?
Decision Making2202339510.250 Why?
Academic Medical Centers1201627830.250 Why?
Antineoplastic Combined Chemotherapy Protocols72011118720.240 Why?
Decompression, Surgical220246030.230 Why?
Quinazolines1201113690.230 Why?
Terminal Care1201617700.220 Why?
Patient Education as Topic1201423370.220 Why?
Cluster Headache12024540.220 Why?
Nervous System Diseases1201416600.220 Why?
Adenocarcinoma3201163600.200 Why?
Castration320111490.180 Why?
Benzamides4200813760.180 Why?
Antineoplastic Agents, Phytogenic120046170.180 Why?
Antineoplastic Agents, Hormonal1200815360.170 Why?
Clinical Competence1201648590.170 Why?
Dicarbethoxydihydrocollidine1201930.170 Why?
Autonomic Dysreflexia1201990.170 Why?
Antineoplastic Agents72011136500.160 Why?
Serotonin Receptor Agonists120191510.150 Why?
Humans4320247670400.150 Why?
Patient Care Planning120239030.140 Why?
Prostate-Specific Antigen6201124630.140 Why?
Vagus Nerve Stimulation120202280.140 Why?
Disease-Free Survival3201168440.120 Why?
Coronary Artery Disease1201465730.110 Why?
Gastrointestinal Diseases1202212050.110 Why?
Patient-Centered Care1202314440.100 Why?
Controlled Clinical Trials as Topic120131870.100 Why?
Middle Aged2120242232330.100 Why?
Drug Administration Schedule5201148550.100 Why?
Spinal Cord Injuries120199270.100 Why?
Trigeminal Autonomic Cephalalgias1201160.090 Why?
Acupuncture12011900.090 Why?
Pressure1201411720.090 Why?
Thalidomide220068860.090 Why?
Male2420243642030.090 Why?
Professional-Patient Relations120167240.090 Why?
Androgens2200912810.090 Why?
Survival Rate32011128230.090 Why?
Snake Venoms12010400.090 Why?
Azasteroids12009370.080 Why?
Ketoconazole12009950.080 Why?
Withholding Treatment120136190.080 Why?
Neoplasms22016223500.080 Why?
Communication1202339040.080 Why?
Injections120118390.080 Why?
Temporomandibular Joint Disorders120112260.080 Why?
Female1320243966600.080 Why?
Administration, Oral3201140260.070 Why?
Organophosphorus Compounds120092090.070 Why?
Adult1220242233170.070 Why?
Syndrome1201432710.070 Why?
Receptor, erbB-3120081420.070 Why?
Neoplasm Metastasis5201048920.070 Why?
Aged1520241713190.070 Why?
Treatment Outcome92024652950.070 Why?
Neoplasms, Hormone-Dependent220064090.070 Why?
Estramustine12006350.070 Why?
Receptor, Platelet-Derived Growth Factor beta120071830.070 Why?
Maximum Tolerated Dose220118960.070 Why?
Aged, 80 and over92011595480.070 Why?
Heart1201944290.060 Why?
Behavior Therapy120118860.060 Why?
Organometallic Compounds120096480.060 Why?
Deoxycytidine220088860.060 Why?
Disease Progression42011136460.060 Why?
Research Support as Topic120096970.060 Why?
Thiazoles1201115300.060 Why?
Placebos1200716600.050 Why?
Patient Compliance1201326970.050 Why?
Receptors, Calcitonin Gene-Related Peptide12022310.050 Why?
Gonadotropin-Releasing Hormone1200811490.050 Why?
Carcinoma, Renal Cell2200831860.050 Why?
Hydrocortisone1200918400.050 Why?
Diphosphonates120066330.050 Why?
Drug Therapy, Combination2200863100.050 Why?
Kidney Neoplasms2200842820.040 Why?
Clinical Trials as Topic2202480480.040 Why?
Imidazoles1200611690.040 Why?
Calcitonin Gene-Related Peptide120223270.040 Why?
Salvage Therapy1200612710.040 Why?
Diagnosis, Differential22014129860.040 Why?
Risk Factors32019748860.040 Why?
Paclitaxel1200617280.040 Why?
Brain22016271630.040 Why?
Bone Marrow1200829260.040 Why?
Physicians1201645930.040 Why?
Interferon-gamma1200631540.040 Why?
Neoadjuvant Therapy1200829020.030 Why?
Orchiectomy220094660.030 Why?
Cross-Sectional Studies22014263250.030 Why?
Protein-Tyrosine Kinases1200424280.030 Why?
Cohort Studies32024417180.030 Why?
Cardiovascular Diseases12019156450.030 Why?
Biomedical Research1200934640.030 Why?
Neurosurgical Procedures1202420750.030 Why?
Drug Delivery Systems1200422120.030 Why?
Infusions, Intravenous2200822270.030 Why?
Dose-Response Relationship, Drug32010107480.020 Why?
Fluorouracil2200816520.020 Why?
Retrospective Studies12020816590.020 Why?
Survival Analysis32008100920.020 Why?
Cholestenone 5 alpha-Reductase12009210.020 Why?
Steroid 17-alpha-Hydroxylase12009990.020 Why?
Military Personnel2200912610.020 Why?
Infusions, Subcutaneous12009430.020 Why?
Epothilones12009420.020 Why?
Drug Resistance, Neoplasm1200453320.020 Why?
Mitoxantrone120091480.020 Why?
Time Factors22010401540.020 Why?
Government Agencies120091610.020 Why?
Radioisotopes120095090.020 Why?
Young Adult12014599800.020 Why?
Treatment Failure1201326580.020 Why?
Magnetic Resonance Imaging12014365820.020 Why?
Alkaline Phosphatase120108610.020 Why?
Collagen Type I120106170.020 Why?
Solubility1200810780.020 Why?
Platelet Count120097840.020 Why?
Disability Evaluation1201318290.020 Why?
Analgesics, Non-Narcotic120093700.020 Why?
Leukocyte Count1200916060.020 Why?
Prednisone1200915660.010 Why?
Constipation120095700.010 Why?
Animals320201689650.010 Why?
Neoplastic Cells, Circulating120109490.010 Why?
Tumor Necrosis Factor-alpha1201443490.010 Why?
Neoplasm Staging22008112170.010 Why?
Fatigue1200915560.010 Why?
Enzyme-Linked Immunosorbent Assay1200838040.010 Why?
Probability1200624760.010 Why?
Prospective Studies12024548860.010 Why?
Bone Density Conservation Agents120067970.010 Why?
Chronic Disease1201393620.010 Why?
Peptides1201043480.010 Why?
Feasibility Studies1200953110.010 Why?
Follow-Up Studies22010393170.010 Why?
Combined Modality Therapy1200985350.010 Why?
Prognosis22008299630.010 Why?
Neutrophils1200937790.010 Why?
Incidence12013215260.010 Why?
Pain1200951010.010 Why?
Proportional Hazards Models12008125360.010 Why?
Depression1201382340.010 Why?
Pilot Projects1200687320.010 Why?
Immunotherapy1200847450.010 Why?
United States12009729710.000 Why?
Mathew's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (185)
Explore
_
Co-Authors (16)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.